| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.3 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.3 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.3 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |